These include compounded versions, other medications in the same drug class, and recently approved generic drugs with similar mechanisms of action
Expect a brief adjustment period of one to two weeks
The Risks of Compounded Semaglutide Lack of FDA Approval and Regulation One of the most critical distinctions between compounded semaglutide and its FDA-approved counterparts is the lack of regulatory oversight
GLP-1 medical weight loss uses prescription medications that mimic naturally occurring hormones to help regulate appetite, slow digestion, and improve how your body processes glucose
Tirzepatide helps patients lose the largest amount of weight (15-21%) compared to most other medications in the weight loss category
The use of GLP-1 RAs, both within and beyond the management of diabetes and obesity, is increasing despite issues with affordability, access to these drugs, and a growing list of potential adverse effects